Joel J Heidelbaugh

Summary

Affiliation: University of Michigan
Country: USA

Publications

  1. ncbi Management of erectile dysfunction
    Joel J Heidelbaugh
    Department of Family Medicine, University of Michigan, Ann Arbor, MI, USA
    Am Fam Physician 81:305-12. 2010
  2. ncbi The perils of prescribing fluoroquinolones
    Joel J Heidelbaugh
    University of Michigan Medical School, Ann Arbor, MI, USA Email
    J Fam Pract 62:191-7. 2013
  3. ncbi The adult well male examination
    Joel J Heidelbaugh
    University of Michigan Medical School, Ann Arbor, MI, USA
    Am Fam Physician 85:964-71. 2012
  4. ncbi Proton pump inhibitors: are they overutilised in clinical practice and do they pose significant risk?
    J J Heidelbaugh
    Department of Family Medicine, University of Michigan, Ann Arbor, MI, USA
    Int J Clin Pract 66:582-91. 2012
  5. ncbi PPI therapy: When to worry about fracture risk
    Joel J Heidelbaugh
    Departments of Family Medicine and Urology, University of Michigan Medical School, Ann Arbor, MI, USA
    J Fam Pract 60:255-60. 2011
  6. ncbi Magnitude and economic effect of overuse of antisecretory therapy in the ambulatory care setting
    Joel J Heidelbaugh
    Department of Family Medicine, University of Michigan, Ann Arbor, MI, USA
    Am J Manag Care 16:e228-34. 2010
  7. ncbi Overutilization of proton pump inhibitors: a review of cost-effectiveness and risk [corrected]
    Joel J Heidelbaugh
    Department of Family Medicine, University of Michigan, Ann Arbor, Michigan, USA
    Am J Gastroenterol 104:S27-32. 2009
  8. ncbi Management of the ingrown toenail
    Joel J Heidelbaugh
    Department of Family Medicine, University of Michigan, Ann Arbor, Michigan, USA
    Am Fam Physician 79:303-8. 2009
  9. ncbi Atypical presentations of gastroesophageal reflux disease
    Joel J Heidelbaugh
    Department of Family Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA
    Am Fam Physician 78:483-8. 2008
  10. ncbi Cirrhosis and chronic liver failure: part II. Complications and treatment
    Joel J Heidelbaugh
    Department of Family Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA
    Am Fam Physician 74:767-76. 2006

Detail Information

Publications13

  1. ncbi Management of erectile dysfunction
    Joel J Heidelbaugh
    Department of Family Medicine, University of Michigan, Ann Arbor, MI, USA
    Am Fam Physician 81:305-12. 2010
    ..Men with ED are at increased risk of coronary, cerebrovascular, and peripheral vascular diseases...
  2. ncbi The perils of prescribing fluoroquinolones
    Joel J Heidelbaugh
    University of Michigan Medical School, Ann Arbor, MI, USA Email
    J Fam Pract 62:191-7. 2013
    ..These broad-spectrum antibiotics--notable for combatting pathogens resistant to other drugs--have a small but noteworthy potential for adverse effects. This review and patient handout highlight signs and symptoms to watch for...
  3. ncbi The adult well male examination
    Joel J Heidelbaugh
    University of Michigan Medical School, Ann Arbor, MI, USA
    Am Fam Physician 85:964-71. 2012
    ..Immunizations should be recommended according to guidelines from the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention...
  4. ncbi Proton pump inhibitors: are they overutilised in clinical practice and do they pose significant risk?
    J J Heidelbaugh
    Department of Family Medicine, University of Michigan, Ann Arbor, MI, USA
    Int J Clin Pract 66:582-91. 2012
    ..While several adverse outcomes have been linked to PPI therapy, most data are from retrospective observational studies that may be subject to confounding and bias...
  5. ncbi PPI therapy: When to worry about fracture risk
    Joel J Heidelbaugh
    Departments of Family Medicine and Urology, University of Michigan Medical School, Ann Arbor, MI, USA
    J Fam Pract 60:255-60. 2011
    ..For most patients with chronic heartburn and regurgitation, step-down therapy to the lowest effective dose of proton pump inhibitors (PPIs) or treatment with a histamine-2 receptor antagonist (H2RA) is a reasonable, cost-effective approach...
  6. ncbi Magnitude and economic effect of overuse of antisecretory therapy in the ambulatory care setting
    Joel J Heidelbaugh
    Department of Family Medicine, University of Michigan, Ann Arbor, MI, USA
    Am J Manag Care 16:e228-34. 2010
    ..To determine the prevalence and economic effect of inappropriate proton pump inhibitor (PPI) use in an ambulatory care setting...
  7. ncbi Overutilization of proton pump inhibitors: a review of cost-effectiveness and risk [corrected]
    Joel J Heidelbaugh
    Department of Family Medicine, University of Michigan, Ann Arbor, Michigan, USA
    Am J Gastroenterol 104:S27-32. 2009
    ....
  8. ncbi Management of the ingrown toenail
    Joel J Heidelbaugh
    Department of Family Medicine, University of Michigan, Ann Arbor, Michigan, USA
    Am Fam Physician 79:303-8. 2009
    ....
  9. ncbi Atypical presentations of gastroesophageal reflux disease
    Joel J Heidelbaugh
    Department of Family Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA
    Am Fam Physician 78:483-8. 2008
    ..However, long-term studies have shown that some patients still require antisecretory therapy and are more likely to develop dysphagia, rectal flatulence, and the inability to belch or vomit...
  10. ncbi Cirrhosis and chronic liver failure: part II. Complications and treatment
    Joel J Heidelbaugh
    Department of Family Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA
    Am Fam Physician 74:767-76. 2006
    ..Survival rates in transplant recipients have improved as a result of advances in immunosuppression and proper risk stratification using the Model for End-Stage Liver Disease and Child-Turcotte-Pugh scoring systems...
  11. ncbi Cirrhosis and chronic liver failure: part I. Diagnosis and evaluation
    Joel J Heidelbaugh
    Department of Family Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA
    Am Fam Physician 74:756-62. 2006
    ....
  12. ncbi Management of gastroesophageal reflux disease
    Joel J Heidelbaugh
    Department of Family Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA
    Am Fam Physician 68:1311-8. 2003
    ..Newer endoscopic modalities, including the Stretta and endocinch procedures, are less invasive and have fewer complications than antireflux surgery, but response rates are lower...
  13. ncbi Magnitude and economic impact of inappropriate use of stress ulcer prophylaxis in non-ICU hospitalized patients
    Joel J Heidelbaugh
    Department of Family Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA
    Am J Gastroenterol 101:2200-5. 2006
    ..Interventions to ensure appropriate use of SUP should decrease resource expenditures without detrimental impact on quality of care...